nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—Gastric irritation—Hydroxyurea—head and neck cancer	0.0406	0.167	CcSEcCtD
Orphenadrine—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.0299	0.123	CcSEcCtD
Orphenadrine—Toremifene—CYP1A1—head and neck cancer	0.0179	0.369	CrCbGaD
Orphenadrine—Warfarin—CYP1A1—head and neck cancer	0.0129	0.266	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—head and neck cancer	0.0106	0.217	CrCbGaD
Orphenadrine—Drowsiness—Hydroxyurea—head and neck cancer	0.0088	0.0363	CcSEcCtD
Orphenadrine—Hallucination—Hydroxyurea—head and neck cancer	0.00786	0.0324	CcSEcCtD
Orphenadrine—Tamoxifen—CYP1A1—head and neck cancer	0.00715	0.147	CrCbGaD
Orphenadrine—Skin disorder—Hydroxyurea—head and neck cancer	0.00545	0.0225	CcSEcCtD
Orphenadrine—Constipation—Vinblastine—head and neck cancer	0.00526	0.0217	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinblastine—head and neck cancer	0.00507	0.0209	CcSEcCtD
Orphenadrine—Somnolence—Hydroxyurea—head and neck cancer	0.00499	0.0206	CcSEcCtD
Orphenadrine—Constipation—Hydroxyurea—head and neck cancer	0.0048	0.0198	CcSEcCtD
Orphenadrine—Vision blurred—Fluorouracil—head and neck cancer	0.00466	0.0192	CcSEcCtD
Orphenadrine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00462	0.0191	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinblastine—head and neck cancer	0.00453	0.0187	CcSEcCtD
Orphenadrine—Asthenia—Vinblastine—head and neck cancer	0.00441	0.0182	CcSEcCtD
Orphenadrine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00413	0.017	CcSEcCtD
Orphenadrine—Confusional state—Fluorouracil—head and neck cancer	0.00407	0.0168	CcSEcCtD
Orphenadrine—Dizziness—Vinblastine—head and neck cancer	0.00407	0.0168	CcSEcCtD
Orphenadrine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00404	0.0166	CcSEcCtD
Orphenadrine—Asthenia—Hydroxyurea—head and neck cancer	0.00403	0.0166	CcSEcCtD
Orphenadrine—Tachycardia—Fluorouracil—head and neck cancer	0.00394	0.0162	CcSEcCtD
Orphenadrine—Vomiting—Vinblastine—head and neck cancer	0.00391	0.0161	CcSEcCtD
Orphenadrine—Headache—Vinblastine—head and neck cancer	0.00385	0.0159	CcSEcCtD
Orphenadrine—Dizziness—Hydroxyurea—head and neck cancer	0.00371	0.0153	CcSEcCtD
Orphenadrine—Nausea—Vinblastine—head and neck cancer	0.00365	0.0151	CcSEcCtD
Orphenadrine—Somnolence—Fluorouracil—head and neck cancer	0.00359	0.0148	CcSEcCtD
Orphenadrine—Vomiting—Hydroxyurea—head and neck cancer	0.00357	0.0147	CcSEcCtD
Orphenadrine—Headache—Hydroxyurea—head and neck cancer	0.00352	0.0145	CcSEcCtD
Orphenadrine—Nausea—Hydroxyurea—head and neck cancer	0.00333	0.0137	CcSEcCtD
Orphenadrine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00333	0.0137	CcSEcCtD
Orphenadrine—Urticaria—Fluorouracil—head and neck cancer	0.00321	0.0132	CcSEcCtD
Orphenadrine—Palpitations—Docetaxel—head and neck cancer	0.00316	0.013	CcSEcCtD
Orphenadrine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00298	0.0123	CcSEcCtD
Orphenadrine—Confusional state—Docetaxel—head and neck cancer	0.00294	0.0121	CcSEcCtD
Orphenadrine—Anaphylactic shock—Docetaxel—head and neck cancer	0.00292	0.012	CcSEcCtD
Orphenadrine—Pruritus—Fluorouracil—head and neck cancer	0.00286	0.0118	CcSEcCtD
Orphenadrine—Tachycardia—Docetaxel—head and neck cancer	0.00285	0.0117	CcSEcCtD
Orphenadrine—Skin disorder—Docetaxel—head and neck cancer	0.00283	0.0117	CcSEcCtD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00277	0.00391	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00275	0.00388	CbGpPWpGaD
Orphenadrine—Dizziness—Fluorouracil—head and neck cancer	0.00267	0.011	CcSEcCtD
Orphenadrine—GRIN1—Alzheimers Disease—TP53—head and neck cancer	0.00263	0.00371	CbGpPWpGaD
Orphenadrine—Somnolence—Docetaxel—head and neck cancer	0.00259	0.0107	CcSEcCtD
Orphenadrine—Vomiting—Fluorouracil—head and neck cancer	0.00257	0.0106	CcSEcCtD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00254	0.00358	CbGpPWpGaD
Orphenadrine—Headache—Fluorouracil—head and neck cancer	0.00253	0.0104	CcSEcCtD
Orphenadrine—Constipation—Docetaxel—head and neck cancer	0.00249	0.0103	CcSEcCtD
Orphenadrine—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.00242	0.00342	CbGpPWpGaD
Orphenadrine—Feeling abnormal—Docetaxel—head and neck cancer	0.0024	0.0099	CcSEcCtD
Orphenadrine—Nausea—Fluorouracil—head and neck cancer	0.0024	0.00989	CcSEcCtD
Orphenadrine—GRIN1—Spinal Cord Injury—MAPK3—head and neck cancer	0.00239	0.00337	CbGpPWpGaD
Orphenadrine—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.00231	0.00325	CbGpPWpGaD
Orphenadrine—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.0023	0.00325	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.0023	0.00325	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—MAPK1—head and neck cancer	0.00227	0.00321	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—EGFR—head and neck cancer	0.00227	0.00321	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00227	0.0032	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00222	0.00314	CbGpPWpGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—HRAS—head and neck cancer	0.00219	0.00309	CbGpPWpGaD
Orphenadrine—Hypersensitivity—Docetaxel—head and neck cancer	0.00215	0.00885	CcSEcCtD
Orphenadrine—GRIN1—BDNF signaling pathway—STAT3—head and neck cancer	0.00213	0.00301	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—KISS1—head and neck cancer	0.00213	0.003	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—STAT3—head and neck cancer	0.00211	0.00297	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—KISS1—head and neck cancer	0.0021	0.00296	CbGpPWpGaD
Orphenadrine—Asthenia—Docetaxel—head and neck cancer	0.00209	0.00862	CcSEcCtD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00208	0.00294	CbGpPWpGaD
Orphenadrine—Pruritus—Docetaxel—head and neck cancer	0.00206	0.0085	CcSEcCtD
Orphenadrine—GRIN1—BDNF signaling pathway—MAPK3—head and neck cancer	0.00204	0.00288	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00202	0.00285	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—MAPK3—head and neck cancer	0.00201	0.00284	CbGpPWpGaD
Orphenadrine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00201	0.00283	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00198	0.0028	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—MAPK1—head and neck cancer	0.00194	0.00274	CbGpPWpGaD
Orphenadrine—Dizziness—Docetaxel—head and neck cancer	0.00193	0.00794	CcSEcCtD
Orphenadrine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.00192	0.00271	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—MAPK1—head and neck cancer	0.00191	0.0027	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TP53—head and neck cancer	0.00191	0.00269	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—NOTCH1—head and neck cancer	0.0019	0.00267	CbGpPWpGaD
Orphenadrine—Vomiting—Docetaxel—head and neck cancer	0.00185	0.00764	CcSEcCtD
Orphenadrine—Headache—Docetaxel—head and neck cancer	0.00183	0.00753	CcSEcCtD
Orphenadrine—HRH1—GPCR ligand binding—GRP—head and neck cancer	0.00175	0.00247	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—NOTCH1—head and neck cancer	0.00174	0.00246	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00174	0.00245	CbGpPWpGaD
Orphenadrine—Nausea—Docetaxel—head and neck cancer	0.00173	0.00714	CcSEcCtD
Orphenadrine—CHRM2—GPCR ligand binding—GRP—head and neck cancer	0.00173	0.00243	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00168	0.00238	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—NOTCH1—head and neck cancer	0.00168	0.00237	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—NOTCH1—head and neck cancer	0.00168	0.00237	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.00167	0.00236	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—PIK3CA—head and neck cancer	0.00166	0.00234	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00162	0.00229	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.00162	0.00229	CbGpPWpGaD
Orphenadrine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.0016	0.00226	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.0016	0.00226	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—MAPK1—head and neck cancer	0.0016	0.00225	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.00159	0.00225	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.00159	0.00224	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.00157	0.00221	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—HRAS—head and neck cancer	0.00156	0.0022	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—VEGFA—head and neck cancer	0.00155	0.00219	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.00154	0.00217	CbGpPWpGaD
Orphenadrine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00152	0.00214	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.0015	0.00212	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00149	0.0021	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.00149	0.0021	CbGpPWpGaD
Orphenadrine—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00148	0.00209	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00147	0.00207	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—MAPK3—head and neck cancer	0.00147	0.00207	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—VEGFA—head and neck cancer	0.00143	0.00201	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—MAPK1—head and neck cancer	0.0014	0.00197	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—EGFR—head and neck cancer	0.0014	0.00197	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—VEGFA—head and neck cancer	0.00138	0.00194	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—VEGFA—head and neck cancer	0.00138	0.00194	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—AKT1—head and neck cancer	0.00137	0.00194	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—NOTCH1—head and neck cancer	0.00137	0.00194	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—AKT1—head and neck cancer	0.00136	0.00191	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—UROD—head and neck cancer	0.00135	0.00191	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—MAPK3—head and neck cancer	0.00135	0.00191	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—UROD—head and neck cancer	0.00132	0.00187	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00131	0.00185	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—MAPK3—head and neck cancer	0.0013	0.00184	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MAPK3—head and neck cancer	0.0013	0.00184	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—MAPK1—head and neck cancer	0.00129	0.00181	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—EGFR—head and neck cancer	0.00128	0.00181	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—HRAS—head and neck cancer	0.00128	0.00181	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—MAPK1—head and neck cancer	0.00124	0.00175	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—MAPK1—head and neck cancer	0.00124	0.00175	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—EGFR—head and neck cancer	0.00124	0.00175	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—EGFR—head and neck cancer	0.00124	0.00175	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—KISS1—head and neck cancer	0.0012	0.0017	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.0012	0.00169	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—KISS1—head and neck cancer	0.00118	0.00167	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	0.00118	0.00167	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—MAPK1—head and neck cancer	0.00114	0.00161	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—VEGFA—head and neck cancer	0.00113	0.00159	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—HRAS—head and neck cancer	0.00112	0.00158	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—VEGFA—head and neck cancer	0.00111	0.00156	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—STAT3—head and neck cancer	0.0011	0.00155	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KISS1—head and neck cancer	0.00109	0.00154	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KISS1—head and neck cancer	0.00108	0.00152	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MAPK3—head and neck cancer	0.00107	0.0015	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MAPK3—head and neck cancer	0.00105	0.00148	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—HRAS—head and neck cancer	0.00103	0.00146	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—VEGFA—head and neck cancer	0.00102	0.00144	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—MAPK1—head and neck cancer	0.00101	0.00143	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—EGFR—head and neck cancer	0.00101	0.00143	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—STAT3—head and neck cancer	0.00101	0.00142	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—MAPK1—head and neck cancer	0.000998	0.00141	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EGFR—head and neck cancer	0.000998	0.00141	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—HRAS—head and neck cancer	0.000995	0.0014	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—HRAS—head and neck cancer	0.000995	0.0014	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GRP—head and neck cancer	0.000991	0.0014	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—VEGFA—head and neck cancer	0.000982	0.00139	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—VEGFA—head and neck cancer	0.000982	0.00139	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GRP—head and neck cancer	0.000975	0.00138	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—STAT3—head and neck cancer	0.000973	0.00137	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—STAT3—head and neck cancer	0.000973	0.00137	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—VEGFA—head and neck cancer	0.000968	0.00137	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MAPK3—head and neck cancer	0.000964	0.00136	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—MAPK1—head and neck cancer	0.000952	0.00134	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MAPK3—head and neck cancer	0.000929	0.00131	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MAPK3—head and neck cancer	0.000929	0.00131	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—HRAS—head and neck cancer	0.000917	0.00129	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—MAPK1—head and neck cancer	0.000917	0.00129	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EGFR—head and neck cancer	0.000917	0.00129	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MAPK3—head and neck cancer	0.000916	0.00129	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GRP—head and neck cancer	0.0009	0.00127	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000896	0.00126	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GRP—head and neck cancer	0.000886	0.00125	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MAPK1—head and neck cancer	0.000884	0.00125	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MAPK1—head and neck cancer	0.000884	0.00125	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EGFR—head and neck cancer	0.000884	0.00125	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EGFR—head and neck cancer	0.000884	0.00125	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—head and neck cancer	0.000879	0.00124	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MAPK1—head and neck cancer	0.000871	0.00123	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—EGFR—head and neck cancer	0.000871	0.00123	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—head and neck cancer	0.000837	0.00118	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—head and neck cancer	0.000836	0.00118	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—HRAS—head and neck cancer	0.000814	0.00115	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—head and neck cancer	0.000804	0.00113	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—HRAS—head and neck cancer	0.000801	0.00113	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—STAT3—head and neck cancer	0.000796	0.00112	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—HRAS—head and neck cancer	0.000764	0.00108	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MAPK3—head and neck cancer	0.00076	0.00107	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000737	0.00104	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—HRAS—head and neck cancer	0.000736	0.00104	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000726	0.00102	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—head and neck cancer	0.000726	0.00102	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MAPK1—head and neck cancer	0.000723	0.00102	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EGFR—head and neck cancer	0.000723	0.00102	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—HRAS—head and neck cancer	0.00071	0.001	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—HRAS—head and neck cancer	0.00071	0.001	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—AKT1—head and neck cancer	0.000707	0.000998	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—HRAS—head and neck cancer	0.000699	0.000987	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000698	0.000985	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—head and neck cancer	0.000691	0.000974	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000689	0.000972	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—STAT3—head and neck cancer	0.000684	0.000965	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000666	0.00094	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MAPK3—head and neck cancer	0.000653	0.000922	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—AKT1—head and neck cancer	0.00065	0.000917	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KISS1—head and neck cancer	0.000646	0.000911	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KISS1—head and neck cancer	0.000635	0.000896	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000634	0.000894	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000634	0.000894	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—AKT1—head and neck cancer	0.000627	0.000884	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—AKT1—head and neck cancer	0.000627	0.000884	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MAPK1—head and neck cancer	0.000622	0.000877	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EGFR—head and neck cancer	0.000622	0.000877	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000615	0.000868	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—UROD—head and neck cancer	0.000614	0.000866	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—HRAS—head and neck cancer	0.000581	0.000819	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NAT2—head and neck cancer	0.000561	0.000792	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00055	0.000776	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NAT2—head and neck cancer	0.00055	0.000776	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GRP—head and neck cancer	0.000532	0.00075	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GRP—head and neck cancer	0.000523	0.000738	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT6—head and neck cancer	0.000516	0.000728	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—AKT1—head and neck cancer	0.000513	0.000723	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.000509	0.000718	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT6—head and neck cancer	0.000508	0.000717	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—HRAS—head and neck cancer	0.000499	0.000704	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—DPYD—head and neck cancer	0.000492	0.000694	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—DPYD—head and neck cancer	0.000482	0.00068	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—YAP1—head and neck cancer	0.000467	0.000659	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—YAP1—head and neck cancer	0.000457	0.000645	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—YAP1—head and neck cancer	0.000457	0.000644	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—YAP1—head and neck cancer	0.000449	0.000634	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—AKT1—head and neck cancer	0.000441	0.000622	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TYMS—head and neck cancer	0.00028	0.000396	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—head and neck cancer	0.000277	0.000391	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TYMS—head and neck cancer	0.000275	0.000387	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—head and neck cancer	0.000271	0.000383	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—head and neck cancer	0.000265	0.000374	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—head and neck cancer	0.000264	0.000373	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	0.000263	0.000371	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—head and neck cancer	0.00026	0.000367	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—head and neck cancer	0.00026	0.000367	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	0.000257	0.000363	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NAT2—head and neck cancer	0.000255	0.00036	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—head and neck cancer	0.00024	0.000338	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—head and neck cancer	0.000236	0.000333	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—DPYD—head and neck cancer	0.000224	0.000315	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—YAP1—head and neck cancer	0.000212	0.000299	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	0.000206	0.00029	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOTCH1—head and neck cancer	0.000203	0.000286	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	0.000193	0.000272	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—head and neck cancer	0.00019	0.000268	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	0.000183	0.000259	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	0.000183	0.000259	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK1—head and neck cancer	0.000181	0.000255	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—head and neck cancer	0.00018	0.000255	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000175	0.000247	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000172	0.000243	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	0.000159	0.000225	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	0.000157	0.000221	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—head and neck cancer	0.000156	0.00022	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—head and neck cancer	0.000153	0.000216	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	0.000147	0.000208	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	0.000145	0.000204	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	0.000143	0.000202	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—head and neck cancer	0.000142	0.0002	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	0.000141	0.000199	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—head and neck cancer	0.000139	0.000197	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—head and neck cancer	0.000138	0.000195	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—head and neck cancer	0.000136	0.000192	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	0.000136	0.000192	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—head and neck cancer	0.000133	0.000188	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—head and neck cancer	0.000133	0.000188	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	0.000131	0.000185	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	0.00013	0.000183	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	0.000128	0.000181	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TYMS—head and neck cancer	0.000127	0.00018	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—head and neck cancer	0.000126	0.000178	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—head and neck cancer	0.000121	0.00017	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	0.00012	0.00017	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	0.000119	0.000168	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—head and neck cancer	0.000119	0.000168	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	0.000118	0.000167	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	0.000117	0.000166	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	0.000114	0.000161	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	0.000112	0.000158	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	0.000108	0.000153	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—head and neck cancer	0.000108	0.000153	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	0.000107	0.00015	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	0.000107	0.00015	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	9.61e-05	0.000136	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	9.42e-05	0.000133	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	9.4e-05	0.000133	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	9.25e-05	0.000131	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—head and neck cancer	9.1e-05	0.000128	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—head and neck cancer	8.95e-05	0.000126	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HRAS—head and neck cancer	8.7e-05	0.000123	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	8.56e-05	0.000121	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—head and neck cancer	7.85e-05	0.000111	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—head and neck cancer	7.69e-05	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—head and neck cancer	7.68e-05	0.000108	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	7.56e-05	0.000107	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.1e-05	0.0001	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—head and neck cancer	6.19e-05	8.74e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.37e-05	6.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—head and neck cancer	3.57e-05	5.04e-05	CbGpPWpGaD
